pharmaphorum September 27, 2022
Nicole Raleigh

AI French-American biotech start-up Owkin recently published new research in the European Journal of Cancer that shows how AI can predict the survival of cancer patients by looking at clinical data and radiology images.

Conducted over a period of three years, in conjunction with leading European cancer centre Gustave Roussy, the PULS-AI project aims to improve cancer care and help doctors better identify those patients most likely to benefit from treatment. And it now looks set to move from mere academic research project to tangible diagnostic product.

With a team of approximately 30 people – working with images from radiology, digital pathology, and oncology – the next step is to become a regulated medical device. Thanks to the radiologists at...

Today's Sponsors


Today's Sponsors

Upfront Healthcare

Today's Sponsor

Curation Health

Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Physician, Provider, Technology
Top 5 stories of the week: Deloitte’s cybersecurity predictions, the true cost of a breach, AI’s new diet
AI will continue to attract investment in near future in the healthcare industry
The power of AI: Advanced algorithm IDs heart issues using Apple Watch data
Closing the Look in AI, EMR and Provider Partnerships: The Key to Improved Population Health Management?
Report: 72% of U.S. workers want to delegate mundane tasks to AI